Telix Pharmaceuticals's total assets for Q4 2024 were AU$1.52B, an increase of 103.29% from the previous quarter. AU:TLX total liabilities were AU$948.22M for the fiscal quarter, a 177.27% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.